HTG Molecular Diagnostics, Inc.
HTGMQ · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $237 | $2,509 | $1,477 | $1,782 |
| - Cash | $12,211 | $9,600 | $22,398 | $7,620 |
| + Debt | $8,353 | $11,710 | $12,644 | $11,254 |
| Enterprise Value | -$3,621 | $4,618 | -$8,276 | $5,417 |
| Revenue | $6,366 | $8,907 | $8,549 | $19,204 |
| % Growth | -28.5% | 4.2% | -55.5% | – |
| Gross Profit | $1,794 | $4,812 | $4,557 | $10,293 |
| % Margin | 28.2% | 54% | 53.3% | 53.6% |
| EBITDA | -$20,140 | -$15,357 | -$18,484 | -$17,078 |
| % Margin | -316.4% | -172.4% | -216.2% | -88.9% |
| Net Income | -$21,594 | -$17,145 | -$20,870 | -$19,298 |
| % Margin | -339.2% | -192.5% | -244.1% | -100.5% |
| EPS Diluted | -24.28 | -29.66 | -54.12 | -91.17 |
| % Growth | 18.1% | 45.2% | 40.6% | – |
| Operating Cash Flow | -$18,408 | -$16,509 | -$16,292 | -$16,696 |
| Capital Expenditures | -$23 | -$644 | -$454 | -$1,103 |
| Free Cash Flow | -$18,431 | -$17,153 | -$16,746 | -$17,799 |